Clinical Trial Update: A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients [Phase 2]

View source ↗

Summary

Phase II trial evaluating the combination of capecitabine and docetaxel in patients with previously untreated advanced non-small cell lung cancer; the study com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Tony Bekaii-Saab | Conditions: Lung Cancer, Non-Small-Cell Lung Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2014-10-06